<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345743</id>
  <title nil="true"/>
  <common-name>(9-bromo-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)-(4-chlorophenyl)methanone</common-name>
  <description>(9-bromo-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)-(4-chlorophenyl)methanone is a chemical compound with the formula C27H18BrClN2O2. With an average molecular weight of 517.80 g/mol, (9-bromo-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)-(4-chlorophenyl)methanone is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>4993216</pubchem-id>
  <chemical-formula>C27H18BrClN2O2</chemical-formula>
  <weight>517.8</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:43:14Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:43:14Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1C2C3=C(C=CC(=C3)Br)OC(N2N=C1C4=CC5=CC=CC=C5C=C4)C(=O)C6=CC=C(C=C6)Cl</moldb-smiles>
  <moldb-formula>C27H18BrClN2O2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H18BrClN2O2/c28-20-9-12-25-22(14-20)24-15-23(19-6-5-16-3-1-2-4-18(16)13-19)30-31(24)27(33-25)26(32)17-7-10-21(29)11-8-17/h1-14,24,27H,15H2</moldb-inchi>
  <moldb-inchikey>WQXHTHDNRXGHJY-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">516.02402</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341636</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(9-bromo-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)-(4-chlorophenyl)methanone</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbonyl compounds</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296098</sync-id>
  <structure-inchikey>WQXHTHDNRXGHJY-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>1800800100000000000000000000002000000000000020040000000000000c0000000000000000000000000000400000000200001000000020800000000000000000800102000200000000010080000000000000110040800400020100008000000001000000501110000000020001800000000000000004800000000100000000000000000000000000008000000000000000084000000000008000000000000000001000001000000000000000000000000100000000000010004000000000000200000010000000000000000001000040000008400400000000400004000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJgAAAIABBgBgAAAAAgIGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:41Z</structure-indexed-at>
</compound>
